ReviewOncoTargets and therapy2020

Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date.

Olivier Bylicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.